Home/Surface Ophthalmics/Charlotte Baenziger

CB

Charlotte Baenziger

Vice President, Clinical Operations

Surface Ophthalmics

Therapeutic Areas

Ophthalmology Dry Eye Syndrome

Surface Ophthalmics Pipeline

Drug	Indication	Phase
Kera Sol Tears	Dry Eye Syndrome	Phase 2
Mycosol (Surf-101)	Dry Eye Syndrome / Ocular Surface Disease	Phase 2
Betasol (Surf-201)	Dry Eye Syndrome / Ocular Inflammation	Phase 2

Leadership Team at Surface Ophthalmics

Richard Lindstrom, MD

Founder & Chairman

Chief Financial Officer

Preeya K. Gupta, MD

Chief Medical Advisor

View full Surface Ophthalmics profile